===
EQS-Ad-hoc: Viromed Medical AG / Key word(s): Miscellaneous
Viromed Medical AG: Viromed Medical GmbH and terraplasma medical GmbH terminate their cooperation with immediate effect
05-Jul-2024 / 17:30 CET/CEST
Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by EQS News
- a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.
Viromed Medical AG: Viromed Medical GmbH and terraplasma medical GmbH terminate their cooperation with immediate effect
Pinneberg, 5 July 2024 - Viromed Medical GmbH, a wholly owned subsidiary of Viromed Medical AG, and terraplasma medical
GmbH have today terminated their business relation with immediate effect.
As part of the previous cooperation, Viromed Medical GmbH held the exclusive distribution rights for a cold plasma
device developed by terraplasma medical GmbH in the German-speaking region (Germany, Austria, Switzerland), with which
Viromed Medical GmbH generated slightly less than half of its annual revenue in the 2023 financial year.
Already in the past, various manufacturers of comparable devices had expressed interest in cooperating with Viromed
Medical GmbH. However, given the exclusivity agreement with terraplasma medical GmbH, Viromed Medical GmbH was unable
to take advantage of these opportunities. This restriction now no longer applies, so that Viromed Medical AG sees the
possibility of expanding its sales potential in future by selling its own cold plasma devices worldwide.
Viromed Medical AG plans to be present on the market with its own cold plasma product series at the beginning of the
fourth quarter of 2024. As a first step, Viromed Medical AG is planning to enter the European market.
Contact Viromed Medical AG
Uwe Perbandt
CEO
Flensburger Strasse 18
25421 Pinneberg
Germany
Email: kontakt@viromed-medical.de
www.viromed-medical-ag.de
End of Inside Information
05-Jul-2024 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press
Releases.

Archive at www.eqs-news.com  
Language:     English 
Company:      Viromed Medical AG 

Flensburger Straße 18
25421 Pinneberg
Germany

Phone:        +49 4101 809960 
E-mail:       kontakt@viromed-medical.de 
Internet:     https://www.viromed-medical-ag.de/ 
ISIN:         DE000A3MQR65 
WKN:          A3MQR6 
Listed:       Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg 
EQS News ID:  1940807 

End of Announcement EQS News Service
===
1940807 05-Jul-2024 CET/CEST

Image link: https://eqs-cockpit.com/cgi-bin/fncls.ssp?fn=show_t_gif&application_id=1940807&application_name=news&site_id=dow_jones%7e%7e%7e43f1f857-252a-44a4-bbde-f4a32f6a5492

END) Dow Jones Newswires

July 05, 2024 11:32 ET (15:32 GMT)